POSTER SESSION V
Wednesday, March 28, 2007 — 9:30 AM - 12:00 Noon
Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
PULMONARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
196
Tissue Microarray Study of Hepsin Expression in Diffuse Malignant Mesothelioma: Potential Target for Therapy
(1496)
LA Litzky, L Garza, TC Allen, PT Cagle - University of Pennsylvania Medical Center, Philadelphia, PA; The Methodist Hospital, Houston, TX; University of Texas Health Center-Tyler, Tyler, TX
MET in Pleural Mesothelioma: Mutational Screening, Phosphorylation Status, and Sensitivity to MET Inhibition
(1521)
S Shimizu, F Lopez-Rios, AB Olshen, V Rusch, M Ladanyi - Memorial Sloan-Kettering Cancer Center, New York, NY
Expression and Prognostic Significance of Aurora Kinases in Pleural Mesothelioma
(1477)
E García-García, C Ballestín, JJ Sánchez, MA Tortoledo, J Sayas, A López Encuentra, L Paz Ares, V Villena, F López-Ríos - Hospital Universitario 12 de Octubre, Madrid, Spain; Universidad Autónoma, Madrid, Spain
P53 and MDM2 Expression in Malignant Pleural Mesothelioma; a Series of 96 Cases
(1476)
F Galateau-Salle, P Vergani, F Morlais, V Rouleau, MC Jaurand, P Rolland, M Paciencia, JC Pairon, M Goldberg, G Launoy - ERI3 INSERM, CHU Caen, Caen, Normandie, France; INSERM, CHU, Caen, Normandie, France; Institut de Veille Sanitaire, Saint Maurice, Ile de France, France
Metastatic Malignant Pleural Mesothelioma in the Mediastinal Lymph Node: A Clinico-Pathologic-Radiologic Study of Seven Cases
(1534)
D Wagner, PA Bourne, BI Goldman, JS Lewis, Jr, H Xu - University of Rochester Medical Center, Rochester, NY; Washington University School of Medicine, St. Louis, MO
Expression of Activated (pSTAT-3) and Inactivated STAT-3, in Malignant Mesothelioma (MM): Possible Role for Chemotherapeutic Intervention
(1454)
R Achcar, PT Cagle, J Jagirdar - University of Texas Health Science Center, San Antonio, TX; Methodist Hospital, Houston and Weill Medical College-Cornell University, NY, NY, Houston, TX
Expression of Galectin-3 in 39 Malignant Mesotheliomas (MM): Potential Target for Therapy
(1479)
JM Gardner, J Zhai, P Cagle - The Methodist Hospital, Weill Medical College of Cornell University, Houston, TX
Immunohistochemical Staining Differences between Malignant Mesothelioma and Squamous Cell Carcinoma
(1470)
T Chang, J Manaligod, M Welker, P Gattuso, R Salgia, V Kohli, T Krausz, AN Husain - University of Chicago, Chicago, IL; Rush Medical Center, Chicago, IL
PTK6 Expression in Normal and Neoplastic Lung Tissues
(1472)
O David, A Tyner, JS Coon - University of Illinois at Chicago, Chicago, IL; Rush University Medical Center, Chicago, IL
Osteoponin and Hypoxia-Inducible Factor-1 Expression in the Lungs of 23 Patients with Sickle Cell Hemoglobinopathy
(1484)
AK Haque, RJ Barrios, AE Sienko, TC Allen, L Garza, CY Castro, PT Cagle - Methodist Hospital, Houston, TX; Univ. of Texas, Tyler, TX; Univ. of Texas, Galveston, TX
GSK3 Blockade Prevents Bleomycin Induced Lung Inflammation and Fibrosis
(1483)
C Gurrieri, FA Piazza, R Niero, E Brunetta, A Cabrelle, M Facco, G Semenzato, C Agostini, C Giacometti, M Valente, F Calabrese - University of Padua, Padua, Italy
Evidence of Epithelial/Mesenchymal Transition in Idiopathic Pulmonary Fibrosis
(1466)
PR Burkett, I Noth, AN Husain - - University of Chicago, Chicago, IL
Differences of Fibroblastic Foci of UIP and Intraalveolar Buds of COP/BOOP, as Measured by Cellular Markers and Growth Factors
(1502)
O Matsubara, N Imazeki, H Tsuda, Y Nakatani, EJ Mark - National Defense Medical College, Tokorozawa, Saitama, Japan; Chiba University, Chiba, Japan; Massachusetts General Hospital and Harvard Medical School, Boston, MA
Cytokine Release from Alveolar Macrophages in Idiopathic Interstitial Pneumonia
(1541)
Q Ye, A Cui, R Sarria, N Freudenberg, S Nakamura, J Guzman, U Costabel - Ruhrlandklinik, Essen, Germany; Basque Country University, Bilbao, Spain; University of Freiburg, Freiburg I. Br., Germany; Nara Medical University, Kashihara, Japan; Ruhr University, Bochum, Germany
Pulmonary Veno-Occlusive Changes: An Under-Recognized Finding in Advanced Pulmonary Langerhans Cell Histiocytosis
(1509)
A Naujokas, KD Jones - - University of California, San Francisco, San Francisco, CA
HIF-1, VEGF and NFKB in Primary Lung Hypertension in a Sheep Model
(1546)
X Zhou, PT Cagle, CY Castro, L Garza, D Wang, SD Lick, JB Zwischenberger - The University of Texas Medical Branch, Galveston, TX; The Methodist Hospital, Houston, TX
C4d Deposition in Lung Allograft Biopsies: Detection by Immunohistochemistry, Correlation with Serum Anti-Donor Antibodies, Histology and Patient Outcome
(1459)
EA Bantle, JH Ritter, EP Trulock, H Liapis - Washington University School of Medicine, St. Louis, MO
The Importance of Pathological Study on Native Lungs Requiring Transplantation: The Padua Experience
(1481)
C Giacometti, M Loy, G Marulli, M Valente, F Rea, F Calabrese - University of Padua, Padua, Italy
Value of Silver Stains on BAL Fluid in Lung Transplant Recipients
(1500)
JM Magill, SS Goldstein, MA Baz, PA Drew - Universtiy of Florida, Gainesville, FL; University of Florida, Gainesville, FL
Granulomatous Reaction to Pneumocystis jirovecii: Clinicopathologic Review of 16 Cases
(1485)
PH Hartel, K Shilo, JR Galvin, TJ Franks - Armed Forces Institute of Pathology, Washington, DC; University of Maryland Medical School, Baltimore, MD
Metagenomic Analysis of Pulmonary Bacterial Microflora in Cystic Fibrosis
(1471)
KS Cunningham, Y Zhang, J Chen, TK Waddell, S Keshavjee, M Liu, DM Hwang - University Health Network, University of Toronto, Toronto, ON, Canada
Clinicopathologic Study of Type 4 Congenital Pulmonary Airway Malformation: Evidence for Distal Acinar Origin
(1501)
H Mani, JT Stocker, K Shilo, JR Galvin, TJ Franks - Armed Forces Institute of Pathology, Washington, DC; Uniformed Services University of the Health Sciences, Bethesda, MD
A Simple Inflation Method for Frozen Diagnosis of Lung Tissue
(1508)
JK Myung, JH Chung, SY Park, DH Chung, JW Seo - Seoul National University College of Medicine, Seoul, Republic of Korea
K Homology Domain Containing Protein Overexpressed in Cancer Is Highly Expressed in Small and Large Cell Neuroendocrine Carcinomas but Not in Carcinoid Tumors of the Lung
(1539)
H Xu, PA Bourne, BO Spaulding, HL Wang - University of Rochester Medical Center, Rochester, NY; Dako North America, Carpinteria, CA; Washington University School of Medicine, St. Louis, MO
The Incidence of Neuroendorine Cell Hyperplasia in Pulmonary Neuroendocrine Tumours and Non-Small Cell Carcinomas
(1516)
SMH Rizvi, J Goodwill, E Lim, YK Yap, P Goldstraw, AG Nicholson - Royal Brompton Hospital, London, United Kingdom
Molecular Profiling of Large Cell Neuroendocrine Carcinoma of Lung and Evaluation of ASCL-1 and KLK11
(1505)
N Motoi, T Motoi, WD Travis, WL Gerald - Memorial Sloan-Kettering Cancer Center, New York, NY
Thyroid Transcription Factor-1 (TTF-1) Expression in Pulmonary Neuroendocrine Carcinomas: Clone-Based Variability
(1515)
N Rassaei, F Tavora, I Ozbudak, W-S Chu, E Jaynes, L Sobin, WD Travis, J Jen, K Shilo, TJ Franks - AFIP, Washington, DC; Memorial Sloan Kettering Cancer Center, New York, NY; National Institutes of Health, Bethesda, MD
Secretin Receptors in Human Lung Cancers: Overexpression in Bronchopulmonary Carcinoids and in Peritumoral Lung Tissue
(1490)
M Körner, GM Hayes, R Rehmann, LJ Miller, JC Reubi - Institute of Pathology, Bern, Switzerland; Mayo Clinic, Scottsdale, AZ
Galectin-4 (LGALS4) Expression in Neuroendocrine Carcinomas and Carcinoid Tumors of the Lung: A Tissue Microarray Study
(1526)
A Sienko, R Barrios, T Allen, L Garza, P Cagle - The Methodist Hospital, Houston, TX; UTHC, Tyler, TX
Large Cell Neuroendocrine Carcinoma — A Distinct Expression Profile Relative to Large Cell Undifferentiated Carcinoma
(1458)
EA Bantle, RJ Battafarano, MA Watson, JS Lewis - Washington University School of Medicine, St. Louis, MO
Trends in Diagnosis of Bronchioloalveolar Carcinoma at University Medical Centers and Affiliated Community Hospitals Following the Shift in the WHO Criteria
(1511)
NP Ohori, KE Schoedel - UPMC-Presbyterian, Pittsburgh, PA
Morphological Analysis of Preinvasive Bronchioloalveolar Carcinoma Noguchi Type B
(1488)
I Ito, T Itaya, T Kameya, H Kondo - Shizuoka Cancer Center, Nagaizumi, Shizuoka, Japan
The Histologic Assessment of Pulmonary Non-Small Cell Carcinoma after Neoadjuvant Therapy
(1465)
WK Brix, WD Ormsby, MR Wick, DR Jones, EB Stelow - University of Virginia, Charlottesville, VA
Oligo- and Polyclonal B Cell Response to Lung Carcinoma Is Common
(1486)
DE Higgs, PN Bogner, DG Hicks, P Starostik, GE Wilding, TL Mashtare, M Merzianu - Roswell Park Cancer Institute, Buffalo, NY
Advancing Edge vs. Center of Non-Small Cell Lung Carcinoma: Assessment of Microvascular Density (MVD)
(1531)
K Suzue, M Tretiakova, C Gong, AN Husain - The University of Chicago Hospitals, Chicago, IL
button next to any title to add to Itinerary Planner...
Add
